Mixing Tirzepatide and Bac Water: Why Licensed Mounjaro Users Don't Need To

Bacteriostatic water (bac water) is used to reconstitute compounded peptide powders; Mounjaro (the UK-licensed tirzepatide) comes pre-filled and ready to inject, so mixing is never part of the process.
Compounded tirzepatide is not MHRA-approved in the UK; only the Eli Lilly KwikPen carries a UK marketing authorisation for weight management.
Unlicensed compounded products sit outside the regulated supply chain, carrying real risks of contamination, incorrect concentration and unknown purity.
Reporting suspected unlicensed or counterfeit injectable products can be done through the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk.

If you've searched for advice on mixing tirzepatide and bac water, it's likely because you've come across compounded or unlicensed tirzepatide online. The licensed version of tirzepatide in the UK, Mounjaro, is supplied by Eli Lilly as a pre-filled KwikPen — no mixing, no vials, no bacteriostatic water required. Compounded tirzepatide, sold in powder or multi-dose vial form, is not approved by the MHRA for use in the UK, and guidance from NHS England and the MHRA confirms that licensed GLP-1 medicines are the only route recommended for weight management. These are prescription-only medicines; a qualified prescriber assesses suitability before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The evidence behind licensed tirzepatide — and why reconstitution questions signal a supply-chain problem

What mixing tirzepatide with bac water actually means, and where the practice comes from

Bacteriostatic water is a sterile solution containing a small concentration of benzyl alcohol, used in clinical and compounding settings to reconstitute lyophilised (freeze-dried) peptides or powders into an injectable liquid. The process requires precise calculations: you draw a measured volume of bac water into a syringe, inject it slowly into a powder vial, swirl gently, then draw up the resulting solution into a separate syringe for injection. Done correctly in a sterile compounding pharmacy, this is a legitimate pharmaceutical technique. Done in someone's kitchen from a product bought online without a prescription (which is exactly the context this search query usually reflects) the risks multiply quickly.

Tirzepatide in its compounded powder form has proliferated on social media and through grey-market websites, typically advertised for "research purposes". In the UK, selling or supplying tirzepatide in this form to individuals for weight management is not authorised by the MHRA. The MHRA's public guidance on GLP-1 medicines makes clear that only licensed products should be used and that people should be cautious of products bought outside the regulated supply chain. The MHRA's Yellow Card scheme exists partly to capture reports of suspect or unlicensed products, and it's worth using it if you encounter them.

There is a separate, more detailed walkthrough of tirzepatide mixing and dosing practices for anyone wanting to understand the compounding context further, and our page covering tirzepatide and bac water goes into the specifics of what that combination involves and why it matters, but the short answer to the practical question is below.

Why licensed Mounjaro users never need to think about this

The SURMOUNT-1 trial (2,539 adults with obesity, 72 weeks, published in the New England Journal of Medicine) studied tirzepatide in the same form Eli Lilly supplies it today: a ready-to-use pre-filled pen. Participants didn't reconstitute anything. They clicked a pen, pressed it to skin and injected. That simplicity was part of the study design, and it's part of why the results (around 20–21% average body-weight reduction at the highest dose) translated reliably across thousands of participants. Standardised delivery matters; home reconstitution introduces a variable that clinical trials deliberately remove.

Mounjaro's UK-licensed KwikPen contains a pre-filled cartridge at a precise, MHRA-verified concentration. Each pen delivers four weekly doses at a fixed strength (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg) with no preparation beyond removing it from the fridge and letting it reach room temperature. The NHS tirzepatide medicines page covers the injection process in plain language, and the patient information leaflet inside every box gives the full instructions.

If you're weighing up whether Mounjaro might be right for you, the full Mounjaro overview covers how it works, what the trial evidence shows and what to expect from treatment.

The real risks when people do mix compounded tirzepatide at home

The MHRA has been direct about this. Enforcement across 2024 and 2025 resulted in seizures of approximately 20 million doses of illegally traded weight-loss medicines (around £45 million at street value) and in October 2025 the first UK site manufacturing counterfeit tirzepatide pens was raided. Counterfeit injectable products have previously contained insulin instead of the labelled peptide, causing hospitalisations. Compounded powders carry different but overlapping risks: incorrect concentration if the bac water volume is miscalculated; bacterial or particulate contamination if sterility isn't maintained; product degradation if storage temperatures weren't controlled at source.

Beyond contamination, there's a dosing problem. The compounded tirzepatide market has no standardised concentration. One vial sold as "5 mg" may contain a different amount than another from a different source, or the same source on a different batch. The titration schedule for tirzepatide exists to limit gastrointestinal side effects while the body adjusts; an accidental overdose from a miscalculated reconstitution can produce severe nausea, vomiting and dehydration quickly. A qualified prescriber reviewing treatment through a licensed tirzepatide programme manages that titration with clinical judgement, not guesswork.

The context around cost is sometimes what drives people toward compounded versions. Since Eli Lilly's UK list price changes from September 2025, private Mounjaro prices have typically ranged roughly £149–£375 per month by dose and provider, as widely reported at the time. That's a real consideration. But for a prescription medicine, the price comparison that matters is between a licensed product at a known concentration and something unlicensed at an unknown one. Those aren't two versions of the same thing.

What a legitimate UK supply chain actually looks like

Any pharmacy dispensing Mounjaro in the UK must be registered with the GPhC and source through the licensed UK supply chain, Eli Lilly's authorised distributors. You can verify any online pharmacy by checking the GPhC pharmacy register; it takes about thirty seconds and it's the single most reliable check available to you. Red flags are consistent: products sold without a clinical consultation, pricing significantly below market rates, sellers operating through Instagram or Telegram, and anything that arrives as a powder requiring reconstitution.

At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber, a real clinician, not an automated screen. Orders placed before 12pm on a working day are dispatched the same day once clinically approved, arriving by DPD the next working day in plain packaging. Treatment, prescription and delivery are included in a single price with no subscription attached. If you'd like to understand whether you're eligible, you can check your eligibility with a free consultation through our clinical team.

For a side-by-side look at the practical steps involved in reconstituting compounded tirzepatide (including the calculations, equipment and sterility requirements) the guide on how to mix bac water and tirzepatide goes into full detail, and explains why those steps are unnecessary for anyone using the licensed product.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions